Rimke C Vos
Overview
Explore the profile of Rimke C Vos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
539
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Versluis A, Boels A, Huijden M, Mijnsbergen M, Rutten G, Vos R
Diabet Med
. 2025 Feb;
:e70002.
PMID: 40007461
Background: Diabetes self-management education (DSME) and support (DSME/S) delivered via mobile health (mHealth) is potentially cost-effective, if proven effective. Objectives: To assess the effectiveness of DSME, DSMS or DSME/S delivered...
2.
Jacobs J, Beekers I, Verkouter I, Richards L, Vegelien A, Bloemsma L, et al.
PLOS Digit Health
. 2025 Jan;
4(1):e0000464.
PMID: 39787064
Precision, or personalised medicine has advanced requirements for medical data management systems (MedDMSs). MedDMS for precision medicine should be able to process hundreds of parameters from multiple sites, be adaptable...
3.
van Grondelle S, Guzel B, Mijnsbergen M, Uitewaal P, Kist J, van Bruggen S, et al.
BMC Prim Care
. 2024 Dec;
25(1):438.
PMID: 39730990
Background: This study aimed to explore the impact of the COVID-19 pandemic and resulting changes to diabetes care, especially concerning disease control, the use of (tele)consultation and lessons worth implementing...
4.
Alfaraj S, Kist J, Groenwold R, Spruit M, Mook-Kanamori D, Vos R
Eur J Prev Cardiol
. 2024 Nov;
PMID: 39485827
Aims: Adults with type 2 diabetes have an increased risk of cardiovascular events (CVE), the world's leading cause of mortality. The SCORE2-Diabetes model is a tool designed to estimate the...
5.
Kist J, Vos H, Vos R, Mairuhu A, Struijs J, Vermeiren R, et al.
Int J Epidemiol
. 2024 Jul;
53(4).
PMID: 39049713
No abstract available.
6.
Andriessen C, Blom M, van Hoek B, de Boer A, Denig P, de Wit G, et al.
Trials
. 2024 Jul;
25(1):505.
PMID: 39049109
Background: Older patients with type 2 diabetes mellitus (T2D) have an increased risk of hypoglycaemic episodes when using sulphonylureas or insulin. In the Netherlands, guidelines exist for reducing glucose-lowering medication...
7.
Laurberg T, Graversen S, Sandbaek A, Wild S, Vos R, Stovring H
Lancet Reg Health Eur
. 2024 May;
41:100909.
PMID: 38707867
Background: Despite advances in primary and secondary prevention of cardiovascular disease, excess mortality persists within the diabetes population. This study explores the components of this excess mortality and their interaction...
8.
Doornenbal B, van Zutphen T, Beumeler L, Vos R, Derks M, Haisma H, et al.
J Patient Rep Outcomes
. 2024 Apr;
8(1):44.
PMID: 38607610
Background: The concept of Positive Health (PH) has gained increasing attention as a way of measuring individuals' ability to adapt in the face of contextual challenges. However, a suitable measurement...
9.
Ter Braake J, Fleetwood K, Vos R, Blackbourn L, McGurnaghan S, Wild S, et al.
Diabetologia
. 2024 Feb;
67(6):1029-1039.
PMID: 38409440
Aims/hypothesis: The aim of this study was to compare cardiovascular risk management among people with type 2 diabetes according to severe mental illness (SMI) status. Methods: We used linked electronic...
10.
Rakers M, van Hattem N, Plag S, Chavannes N, van Os H, Vos R
Front Med (Lausanne)
. 2024 Jan;
10:1275267.
PMID: 38239619
Introduction: Cardiometabolic diseases (CMD) are the leading cause of death in high-income countries and are largely attributable to modifiable risk factors. Population health management (PHM) can effectively identify patient subgroups...